🇺🇸 FDA
Patent

US 6380403

Illudin analogs useful as antitumor agents

expired A61PA61P35/00A61P35/04

Quick answer

US patent 6380403 (Illudin analogs useful as antitumor agents) held by The Regents of the University of California expires Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Apr 30 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
2
CPC classes
A61P, A61P35/00, A61P35/04